Table 3.
Age‐standardized incidence rates of neuroendocrine neoplasms by 5‐year intervals, sex, and tumor type in the lung and gastroenteropancreatic (GEP) tract by tumor type. Rates are per 100,000 and age‐adjusted to the 1976 European standard population
| Incidence year interval | Men | Women | ||||||
|---|---|---|---|---|---|---|---|---|
| Lung | GEP | Lung | GEP | |||||
| NET | NEC | NET | NEC | NET | NEC | NET | NEC | |
| 1976–1980 | 0.60 | 15.73 | 2.26 | 0.16 | 0.39 | 1.14 | 2.27 | 0.03 |
| 1981–1985 | 0.48 | 16.66 | 1.60 | 0.17 | 0.64 | 2.60 | 1.87 | 0.05 |
| 1986–1990 | 0.26 | 17.09 | 2.96 | 0.13 | 0.47 | 2.48 | 2.78 | 0.00 |
| 1991–1995 | 0.63 | 13.69 | 2.65 | 0.11 | 0.42 | 3.92 | 2.12 | 0.02 |
| 1996–2000 | 1.27 | 10.86 | 2.36 | 0.58 | 0.59 | 4.77 | 2.05 | 0.24 |
| 2001–2005 | 0.45 | 10.84 | 2.32 | 0.56 | 0.37 | 5.21 | 2.41 | 0.46 |
| 2006–2010 | 0.46 | 9.27 | 4.21 | 0.62 | 0.71 | 4.70 | 3.10 | 0.60 |
| 2011–2016 | 0.74 | 8.50 | 3.55 | 0.90 | 1.19 | 5.05 | 3.70 | 0.50 |
Abbreviations: GEP, gastroenteropancreatic; NET, neuroendocrine tumors; NEC, neuroendocrine carcinomas.